Citrullinated inter‐alpha‐trypsin inhibitor heavy chain 4 in arthritic joints and its potential effect in the neutrophil migration
Author(s) -
Osada A.,
Matsumoto I.,
Mikami N.,
Ohyama A.,
Kurata I.,
Kondo Y.,
Tsuboi H.,
Ishigami A.,
Sano Y.,
Arai T.,
Ise N.,
Sumida T.
Publication year - 2021
Publication title -
clinical & experimental immunology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.329
H-Index - 135
eISSN - 1365-2249
pISSN - 0009-9104
DOI - 10.1111/cei.13556
Subject(s) - rheumatoid arthritis , immunology , arthritis , antibody , blot , biomarker , antigen , chemistry , medicine , biochemistry , gene
In this study, we presented clear evidence of the increased expression of citrullinated inter‐alpha‐trypsin inhibitor heavy chain 4 (cit‐ITIH4) both in joints from peptide glucose‐6‐phosphate isomerase‐induced arthritis (pGIA) mice and rheumatoid arthritis patients. Neutrophils with PAD4 in joints might contribute to this citrullination, which was shown by decreases in ITIH4 citrullination upon depletion of neutrophils by anti‐Ly6G antibodies in pGIA mice. In addition, we demonstrated that the citrullination of ITIH4 enhanced the migration of human neutrophils, supporting an association between cit‐ITIH4 and the generation of arthritis.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom